HomeStrategic AdvisoryFinancingOur TeamNews & EventsContact Us
Green Bar Insight Into Value Through Deep Data

Data Driven ValuationsFocus on Life SciencesSupport at All Stages

Our team has decades of experience in valuation work. Our philosophy is that validation of data through multiple sources yields higher fidelity and more credible valuations.  Consequently, we endeavor to incorporate as many complementary data sources into our valuation work as possible.  

We access numerous secondary sources to build a composite framework for valuation analysis, and we are able to integrate information from disparate sources into a single cohesive analytical structure.  Additionally, we have the expertise to strategically integrate primary research into our asset valuations, having conducted more than 1,000 primary research interviews with clinicians, payers, and other experts from the US and EU.

Importantly, we understand that data and valuation analysis is unlikely to achieve the desired effect in negotiations without a clearly articulated value story to accompany the quantitative aspects of the work. Our valuation work goes beyond the numbers to provide a compelling case for the value and valuation that your asset or company possess.

All Investment Banking Services and Securities offered through Independent Investment Bankers Corp. a broker-dealer, member FINRA and SIPC. BioPharma Capital, LLC is not affiliated with Independent Investment Bankers Corp. Check the background of this firm on FINRA's BrokerCheck.

Contact   |    Privacy    |    Terms of Use

©2016 BioPharma Capital

BioPharma Capital, LLC   Cambridge, MA   USA
Phone: +1 619 208-8439